Victor L. Campbell | HCA Healthcare, Inc. |
R. Milton Johnson | HCA Healthcare, Inc. |
William B. Rutherford | HCA Healthcare, Inc. |
Samuel N. Hazen | HCA Healthcare, Inc. |
A.J. Rice | Credit Suisse Securities (NYSE:USA) LLC |
Frank George Morgan | RBC Capital Markets LLC |
Justin Lake | Wolfe Research LLC |
Matthew Borsch | BMO Capital Markets (United States) |
Ralph Giacobbe | Citigroup Global Markets, Inc. |
Peter Heinz Costa | Wells Fargo Securities LLC |
Matthew D. Gillmor | Robert W. Baird & Co., Inc. |
Joshua Raskin | Nephron Research LLC |
Brian Gil Tanquilut | Jefferies LLC |
Sarah E. James | Piper Jaffray & Co. |
Ana A. Gupte | Leerink Partners LLC |
Stephen Tanal | Goldman Sachs & Co. LLC |
Kevin Mark Fischbeck | Bank of America Merrill Lynch |
Good day, everyone, and welcome to the HCA second quarter 2018 earnings conference call. Please note that this call is being recorded. And at this time for opening remarks and introductions, I'd like to turn the call over to the Senior Vice President, Mr. Vic Campbell. Please go ahead, sir.